研究简报

新型4-芳基-5,6,7,8-四氢喹唑啉-2-胺类化合物的合成及其生物活性研究

  • 鲍名凯 ,
  • 熊丝丝 ,
  • 曹明珍 ,
  • 徐徐 ,
  • 王石发 ,
  • 张志杰
展开
  • a. 南京林业大学化学工程学院 南京 210037;
    b. 中国中医科学院中药研究所 北京 100700

收稿日期: 2014-04-12

  修回日期: 2014-05-07

  网络出版日期: 2014-06-11

基金资助

国家林业公益性行业科研专项(No.201104015)和国家自然科学基金(No.31170538)资助项目.

Synthesis and Biological Activities of Novel 4-Aryl-5,6,7,8-tetrahydroquinazolin-2-amine Derivatives

  • Bao Mingkai ,
  • Xiong Sisi ,
  • Cao Mingzhen ,
  • Xu Xu ,
  • Wang Shifa ,
  • Zhang Zhijie
Expand
  • a. College of Chemical Engineering, Nanjing Forestry University, Nanjing 210037;
    b. Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700

Received date: 2014-04-12

  Revised date: 2014-05-07

  Online published: 2014-06-11

Supported by

Project supported by Forestry Public Sector Research Found of State Forestry Administration of China (No. 201104015) and the National Natural Science Foundation of China (No. 31170538).

摘要

α-蒎烯为原料,经加成-氧化后与多种芳香醛缩合制得中间体4-芳亚甲基异松蒎酮3a3h3a3h与盐酸胍在叔丁醇钾催化作用下合成8种新型4-芳取代-5,6,7,8,-四氢喹唑啉-2-胺类化合物4a4h. 其结构经IR,1H NMR,13C NMR,GC-MS和元素分析表征. 初步探讨了所合成化合物对人乳腺癌细胞MCF-7和人肺癌细胞A549的体外生物活性,结果显示部分化合物具有很好的抗肿瘤活性.

本文引用格式

鲍名凯 , 熊丝丝 , 曹明珍 , 徐徐 , 王石发 , 张志杰 . 新型4-芳基-5,6,7,8-四氢喹唑啉-2-胺类化合物的合成及其生物活性研究[J]. 有机化学, 2014 , 34(10) : 2130 -2134 . DOI: 10.6023/cjoc201404021

Abstract

The intermediate compounds 4-arylidene isopinanones 3a3h were synthesized by using α-pinene as starting material in three steps reaction including addition, oxidation, and condensation with aromatic aldehydes. Subsequently, eight new 4-aryl-5,6,7,8-tetrahydroquinazolin-2-amine derivatives 4a4h were obtained by reacting 3a3h with guanidine hydrochloride under t-BuOK. Their structures were characterized by IR, 1H NMR, 13C NMR, GC-MS and elemental analysis. Biological activities of 4a4h against MCF-7 (human breast cancer) and A549 (human lung cancer) were tested and the results showed that some of compounds exhibited good antitumor activity.

参考文献

[1] Laddha, S. S.; Bhatnagar, S. P. Bioorg. Med. Chem. 2009, 17, 6796.
[2] Mclaughlin, N. P.; Evans, P. J. Org. Chem. 2010, 75, 518.
[3] Manjula, S. N.; Bharath, E. N.; Divya, B. Int. J. Pharmacol. Biol. Sci. 2011, 2, 780.
[4] Selvam, T. P.; Kumar, P. V.; Kumar, A. S. J. Pharm. Res. 2010, 3, 1637.
[5] Yang, S. H.; Khadka, D. B.; Cho, S. H. Bioorg. Med. Chem. 2011, 19, 968.
[6] Fry, D. W.; Kraker, A. J.; McMichael, A.; Ambroso, L. A.; Nelson, J. M.; Bridges, A. J. Science 1994, 265, 1903.
[7] Moasser, M. M.; Basso, A.; Averbuch, S. D.; Rosen, N. Cancer Res. 2001, 61, 7184.
[8] Ashkenazi A J. WO 2006089015, 2006 [Chem, Abstr. 2006, 84, 137558].
[9] Sabitha, K.; Kishore, K. M.; Kaiser, J. J. Mol. Graphics Modell. 2008, 27, 238.
[10] Song, Y.; Gang, L.; Song, B. A. J. Org. Chem. 2006, 26, 1429.
[11] Magda, N. N.; Magdy, M. G.; Eman, R. E. Arch. Pharm. 2003, 336, 560.
[12] Liu, H. B.; Xu, H. J.; Lv, P.; Pan, N. N.; Li, S. Q. Acta Chim. Sinica 2012, 70, 674 (in Chinese).
(刘海彬, 徐慧娟, 吕萍, 潘宁宁, 李双奇, 化学学报, 2012, 70, 674.)
[13] Wei, B. S.; Xu, X.; Yang, Y. Q.; Cao, X. Q.; Wang, S. F. Chin. J. Org. Chem. 2012, 32, 2287 (in Chinese).
(魏柏松, 徐徐, 杨益琴, 曹晓琴, 王石发, 有机化学, 2012, 32, 2287.)
[14] Yang, Y. Q.; Li, Y. P.; Wang, S. F.; Gu, W. Chin. J. Org. Chem. 2009, 29, 1082 (in Chinese).
(杨益琴, 李艳苹, 王石发, 谷文, 有机化学, 2009, 29, 1082.)
[15] Wang, S. F.; Li, Y. P.; Zhang, M. G. Chin. J. Org. Chem. 2007, 27, 1612 (in Chinese).
(王石发, 李艳苹, 张明光, 有机化学, 2007, 27, 1612.)

文章导航

/